
Arthroplasty
No benefits of preoperative autologous donation for hip replacement
J Bone Joint Surg Am. 2002 Aug;84-A(8):1299-30496 patients undergoing primary total hip arthroplasty were randomized either to donate two units of blood (autologous donors) or to not donate any blood (nondonors). Patients were compared in terms of blood loss volumes, hemoglobin measurements, and transfusion rates over 6 weeks. No benefits were seen for autologous donation patients, and they were more likely to receive an autologous transfusion than nondonors.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.